February 20, 2026 02:43 pm (IST)
Follow us:
Lupin launches generic Aricept tablets in the US
Mumbai/ Baltimore, Mar 31 (IBNS) Mumbai-based Lupin Limited (Lupin), a transnational pharmaceutical company producing and developing a wide range of branded and generic formulations, biotechnology products and APIs globally, announced on Thursday that its US subsidiary, Lupin Pharmaceuticals Inc. has launched its Donepezil Hydrochloride Tablets, 23 mg having received approval from the United States Food and Drug Administration (FDA) earlier to market a generic equivalent of Eisai Inc's Aricept® Tablets, 23mg.
Headquartered in Baltimore, Maryland, Lupin Pharmaceuticals, Inc. works in the area of generic medicines and branded formulations.
Lupin's Donepezil Hydrochloride Tablets, 23 mg are the AB rated generic equivalent of Eisai Inc's Aricept® Tablets, 23mg. It is indicated for the treatment of dementia of the Alzheimer's type.
Aricept® had US sales of USD 47.1 million (IMS MAT December 2015).
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Big boost for India! PM Modi announces major India–France aviation skills hub in Kanpur
Fri, Feb 20 2026
Which International ETF Belongs in Your Portfolio?
Thu, Feb 19 2026
No more tax payment hassles! Bandhan Bank unlocks instant challan and 24×7 payment access in Assam
Thu, Feb 19 2026
Tata Group joins hands with OpenAI in massive AI push to transform India and global industries
Thu, Feb 19 2026
Affordable and aggressive! Nissan launches Gravite at Rs. 5.65 Lakh
Wed, Feb 18 2026